A randomised open-label immunogenicity study of the 10 Valent Pneumococcal vaccine (PCV10) given as part of the routine infant immunisation schedule to children in Kathmandu, Nepal.

Trial Profile

A randomised open-label immunogenicity study of the 10 Valent Pneumococcal vaccine (PCV10) given as part of the routine infant immunisation schedule to children in Kathmandu, Nepal.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2015

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics; Registrational
  • Acronyms PCV10
  • Most Recent Events

    • 01 Nov 2011 Actual end date (31 Oct 2011) added as reported by ISRCTN: Current Controlled Trials.
    • 01 Nov 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 10 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top